Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion

Context: Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR. Objective: Our objective was to investigate CVR in patients with NFAI. Design and Setting: Thi...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism Vol. 99; no. 8; pp. 2754 - 2762
Main Authors: Androulakis, Ioannis I, Kaltsas, Gregory A, Kollias, Georgios E, Markou, Athina C, Gouli, Aggeliki K, Thomas, Dimitrios A, Alexandraki, Krystallenia I, Papamichael, Christos M, Hadjidakis, Dimitrios J, Piaditis, George P
Format: Journal Article
Language:English
Published: Bethesda, MD Endocrine Society 01-08-2014
Copyright by The Endocrine Society
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Context: Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR. Objective: Our objective was to investigate CVR in patients with NFAI. Design and Setting: This case-control study was performed in a tertiary general hospital. Subjects: Subjects included 60 normotensive euglycemic patients with AI and 32 healthy controls (C) with normal adrenal imaging. Main Outcome Measures: All participants underwent adrenal imaging, biochemical and hormonal evaluation, and the following investigations: 1) measurement of carotid intima-media thickness (IMT) and flow-mediated dilatation, 2) 2-hour 75-gram oral glucose tolerance test and calculation of insulin resistance indices (homeostasis model assessment, quantitative insulin sensitivity check, and Matsuda indices), 3) iv ACTH stimulation test, 4) low-dose dexamethasone suppression test, and 5) NaCl (0.9%) post-dexamethasone saline infusion test. Results: Based on cutoffs obtained from controls, autonomous cortisol secretion was documented in 26 patients (cortisol-secreting AI [CSAI] group), whereas 34 exhibited adequate cortisol and aldosterone suppression (NFAI group). IMT measurements were higher and flow-mediated vasodilatation was lower in the CSAI group compared with both NFAI and C and in the NFAI group compared with C. The homeostasis model assessment index was higher and quantitative insulin sensitivity check index and Matsuda indices were lower in the CSAI and NFAI groups compared with C as well as in CSAI compared with the NFAI group. The area under the curve for cortisol after ACTH stimulation was higher in the CSAI group compared with the NFAI group and C and in the NFAI group compared with C. In the CSAI group, IMT correlated with cortisol, urinary free cortisol, and cortisol after a low-dose dexamethasone suppression test, whereas in the NFAI group, IMT correlated with area under the curve for cortisol after ACTH stimulation and urinary free cortisol. Conclusions: Patients with CSAI without hypertension, diabetes, and/or dyslipidemia exhibit adverse metabolic and CVR factors. In addition, NFAIs are apparently associated with increased insulin resistance and endothelial dysfunction that correlate with subtle but not autonomous cortisol excess.
AbstractList CONTEXT:Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR. OBJECTIVE:Our objective was to investigate CVR in patients with NFAI. DESIGN AND SETTING:This case-control study was performed in a tertiary general hospital. SUBJECTS:Subjects included 60 normotensive euglycemic patients with AI and 32 healthy controls (C) with normal adrenal imaging. MAIN OUTCOME MEASURES:All participants underwent adrenal imaging, biochemical and hormonal evaluation, and the following investigations1) measurement of carotid intima-media thickness (IMT) and flow-mediated dilatation, 2) 2-hour 75-gram oral glucose tolerance test and calculation of insulin resistance indices (homeostasis model assessment, quantitative insulin sensitivity check, and Matsuda indices), 3) iv ACTH stimulation test, 4) low-dose dexamethasone suppression test, and 5) NaCl (0.9%) post-dexamethasone saline infusion test. RESULTS:Based on cutoffs obtained from controls, autonomous cortisol secretion was documented in 26 patients (cortisol-secreting AI [CSAI] group), whereas 34 exhibited adequate cortisol and aldosterone suppression (NFAI group). IMT measurements were higher and flow-mediated vasodilatation was lower in the CSAI group compared with both NFAI and C and in the NFAI group compared with C. The homeostasis model assessment index was higher and quantitative insulin sensitivity check index and Matsuda indices were lower in the CSAI and NFAI groups compared with C as well as in CSAI compared with the NFAI group. The area under the curve for cortisol after ACTH stimulation was higher in the CSAI group compared with the NFAI group and C and in the NFAI group compared with C. In the CSAI group, IMT correlated with cortisol, urinary free cortisol, and cortisol after a low-dose dexamethasone suppression test, whereas in the NFAI group, IMT correlated with area under the curve for cortisol after ACTH stimulation and urinary free cortisol. CONCLUSIONS:Patients with CSAI without hypertension, diabetes, and/or dyslipidemia exhibit adverse metabolic and CVR factors. In addition, NFAIs are apparently associated with increased insulin resistance and endothelial dysfunction that correlate with subtle but not autonomous cortisol excess.
Context: Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR. Objective: Our objective was to investigate CVR in patients with NFAI. Design and Setting: This case-control study was performed in a tertiary general hospital. Subjects: Subjects included 60 normotensive euglycemic patients with AI and 32 healthy controls (C) with normal adrenal imaging. Main Outcome Measures: All participants underwent adrenal imaging, biochemical and hormonal evaluation, and the following investigations: 1) measurement of carotid intima-media thickness (IMT) and flow-mediated dilatation, 2) 2-hour 75-gram oral glucose tolerance test and calculation of insulin resistance indices (homeostasis model assessment, quantitative insulin sensitivity check, and Matsuda indices), 3) iv ACTH stimulation test, 4) low-dose dexamethasone suppression test, and 5) NaCl (0.9%) post-dexamethasone saline infusion test. Results: Based on cutoffs obtained from controls, autonomous cortisol secretion was documented in 26 patients (cortisol-secreting AI [CSAI] group), whereas 34 exhibited adequate cortisol and aldosterone suppression (NFAI group). IMT measurements were higher and flow-mediated vasodilatation was lower in the CSAI group compared with both NFAI and C and in the NFAI group compared with C. The homeostasis model assessment index was higher and quantitative insulin sensitivity check index and Matsuda indices were lower in the CSAI and NFAI groups compared with C as well as in CSAI compared with the NFAI group. The area under the curve for cortisol after ACTH stimulation was higher in the CSAI group compared with the NFAI group and C and in the NFAI group compared with C. In the CSAI group, IMT correlated with cortisol, urinary free cortisol, and cortisol after a low-dose dexamethasone suppression test, whereas in the NFAI group, IMT correlated with area under the curve for cortisol after ACTH stimulation and urinary free cortisol. Conclusions: Patients with CSAI without hypertension, diabetes, and/or dyslipidemia exhibit adverse metabolic and CVR factors. In addition, NFAIs are apparently associated with increased insulin resistance and endothelial dysfunction that correlate with subtle but not autonomous cortisol excess.
Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR. Our objective was to investigate CVR in patients with NFAI. This case-control study was performed in a tertiary general hospital. SUBJECTS included 60 normotensive euglycemic patients with AI and 32 healthy controls (C) with normal adrenal imaging. All participants underwent adrenal imaging, biochemical and hormonal evaluation, and the following investigations: 1) measurement of carotid intima-media thickness (IMT) and flow-mediated dilatation, 2) 2-hour 75-gram oral glucose tolerance test and calculation of insulin resistance indices (homeostasis model assessment, quantitative insulin sensitivity check, and Matsuda indices), 3) iv ACTH stimulation test, 4) low-dose dexamethasone suppression test, and 5) NaCl (0.9%) post-dexamethasone saline infusion test. Based on cutoffs obtained from controls, autonomous cortisol secretion was documented in 26 patients (cortisol-secreting AI [CSAI] group), whereas 34 exhibited adequate cortisol and aldosterone suppression (NFAI group). IMT measurements were higher and flow-mediated vasodilatation was lower in the CSAI group compared with both NFAI and C and in the NFAI group compared with C. The homeostasis model assessment index was higher and quantitative insulin sensitivity check index and Matsuda indices were lower in the CSAI and NFAI groups compared with C as well as in CSAI compared with the NFAI group. The area under the curve for cortisol after ACTH stimulation was higher in the CSAI group compared with the NFAI group and C and in the NFAI group compared with C. In the CSAI group, IMT correlated with cortisol, urinary free cortisol, and cortisol after a low-dose dexamethasone suppression test, whereas in the NFAI group, IMT correlated with area under the curve for cortisol after ACTH stimulation and urinary free cortisol. Patients with CSAI without hypertension, diabetes, and/or dyslipidemia exhibit adverse metabolic and CVR factors. In addition, NFAIs are apparently associated with increased insulin resistance and endothelial dysfunction that correlate with subtle but not autonomous cortisol excess.
CONTEXTAlthough adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with nonfunctioning AI (NFAI) have increased CVR.OBJECTIVEOur objective was to investigate CVR in patients with NFAI.DESIGN AND SETTINGThis case-control study was performed in a tertiary general hospital.SUBJECTSSUBJECTS included 60 normotensive euglycemic patients with AI and 32 healthy controls (C) with normal adrenal imaging.MAIN OUTCOME MEASURESAll participants underwent adrenal imaging, biochemical and hormonal evaluation, and the following investigations: 1) measurement of carotid intima-media thickness (IMT) and flow-mediated dilatation, 2) 2-hour 75-gram oral glucose tolerance test and calculation of insulin resistance indices (homeostasis model assessment, quantitative insulin sensitivity check, and Matsuda indices), 3) iv ACTH stimulation test, 4) low-dose dexamethasone suppression test, and 5) NaCl (0.9%) post-dexamethasone saline infusion test.RESULTSBased on cutoffs obtained from controls, autonomous cortisol secretion was documented in 26 patients (cortisol-secreting AI [CSAI] group), whereas 34 exhibited adequate cortisol and aldosterone suppression (NFAI group). IMT measurements were higher and flow-mediated vasodilatation was lower in the CSAI group compared with both NFAI and C and in the NFAI group compared with C. The homeostasis model assessment index was higher and quantitative insulin sensitivity check index and Matsuda indices were lower in the CSAI and NFAI groups compared with C as well as in CSAI compared with the NFAI group. The area under the curve for cortisol after ACTH stimulation was higher in the CSAI group compared with the NFAI group and C and in the NFAI group compared with C. In the CSAI group, IMT correlated with cortisol, urinary free cortisol, and cortisol after a low-dose dexamethasone suppression test, whereas in the NFAI group, IMT correlated with area under the curve for cortisol after ACTH stimulation and urinary free cortisol.CONCLUSIONSPatients with CSAI without hypertension, diabetes, and/or dyslipidemia exhibit adverse metabolic and CVR factors. In addition, NFAIs are apparently associated with increased insulin resistance and endothelial dysfunction that correlate with subtle but not autonomous cortisol excess.
Author Kollias, Georgios E
Papamichael, Christos M
Kaltsas, Gregory A
Hadjidakis, Dimitrios J
Thomas, Dimitrios A
Markou, Athina C
Piaditis, George P
Gouli, Aggeliki K
Alexandraki, Krystallenia I
Androulakis, Ioannis I
AuthorAffiliation Department of Endocrinology and Diabetes (I.I.A., A.C.M., A.K.G., G.P.P.), General Hospital of Athens “G. Gennimatas,” and Endocrine Unit (G.A.K., D.A.T., K.I.A.), Department of Pathophysiology, National University of Athens, 11527 Athens, Greece; Endocrine Unit (I.I.A., D.J.H.), Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, 12462 Athens, Greece; and Vascular Laboratory (G.E.K., C.M.P.), Department of Therapeutics, Alexandra Hospital, School of Medicine, University of Athens, 11528 Athens, Greece
AuthorAffiliation_xml – name: Department of Endocrinology and Diabetes (I.I.A., A.C.M., A.K.G., G.P.P.), General Hospital of Athens “G. Gennimatas,” and Endocrine Unit (G.A.K., D.A.T., K.I.A.), Department of Pathophysiology, National University of Athens, 11527 Athens, Greece; Endocrine Unit (I.I.A., D.J.H.), Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, 12462 Athens, Greece; and Vascular Laboratory (G.E.K., C.M.P.), Department of Therapeutics, Alexandra Hospital, School of Medicine, University of Athens, 11528 Athens, Greece
Author_xml – sequence: 1
  givenname: Ioannis I
  surname: Androulakis
  fullname: Androulakis, Ioannis I
  email: iandroulakis@gmail.com
– sequence: 2
  givenname: Gregory A
  surname: Kaltsas
  fullname: Kaltsas, Gregory A
– sequence: 3
  givenname: Georgios E
  surname: Kollias
  fullname: Kollias, Georgios E
– sequence: 4
  givenname: Athina C
  surname: Markou
  fullname: Markou, Athina C
– sequence: 5
  givenname: Aggeliki K
  surname: Gouli
  fullname: Gouli, Aggeliki K
– sequence: 6
  givenname: Dimitrios A
  surname: Thomas
  fullname: Thomas, Dimitrios A
– sequence: 7
  givenname: Krystallenia I
  surname: Alexandraki
  fullname: Alexandraki, Krystallenia I
– sequence: 8
  givenname: Christos M
  surname: Papamichael
  fullname: Papamichael, Christos M
– sequence: 9
  givenname: Dimitrios J
  surname: Hadjidakis
  fullname: Hadjidakis, Dimitrios J
– sequence: 10
  givenname: George P
  surname: Piaditis
  fullname: Piaditis, George P
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28919669$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24712565$$D View this record in MEDLINE/PubMed
BookMark eNptkUtv1DAQgC1URLeFG2fkCxIHUmzHSZzjdmmhUnmIh-BmOc6Y9dZrBztpu3-BX42jXeCCL5bH38zY35ygIx88IPSUkjPKKHm10WeM0LLgpOYP0IK2vCoa2jZHaEEIo0XbsO_H6CSlDSGU86p8hI4Zbyir6mqBfn1UowU_JvzNjmu8HAYV89Ht8PvgzeT1aIO3_gde9jmuHL7y2vaZUC5sVcLv1A6fA1bjfBFBJejxSsXehluV9ORUxJ9susGvJ8BjwBf3GlKyt4BXIY42BYc_Q86buzxGD41yCZ4c9lP09fLiy-ptcf3hzdVqeV1ozgUtTG86pjphgHeCloYDEyVXgjYVM9S0nPUdiKqvahC17juqK6qEbkQ3RwgpT9GLfd0hhp8TpFFubdLgnPIQpiRpVbGybmpaZ_TlHtUxpBTByCHarYo7SYmc7cuNlrN9OdvP-LND5anbQv8X_qM7A88PQJajnIkq20z_ONHStq7bzPE9dxfcCDHduOkOolyDcuNakrx43Ygid-Ykf4kUZB51Tiv3aeD7oKP1MMSsW27CFPPs0v9f_RsXtLGD
CODEN JCEMAZ
CitedBy_id crossref_primary_10_1007_s42000_021_00308_z
crossref_primary_10_1530_EJE_16_0467
crossref_primary_10_1111_cen_14861
crossref_primary_10_3389_fendo_2024_1385808
crossref_primary_10_1016_j_eprac_2022_11_009
crossref_primary_10_1111_cen_14745
crossref_primary_10_1530_EJE_14_0537
crossref_primary_10_3390_ijms23020673
crossref_primary_10_1038_s41588_021_00852_9
crossref_primary_10_3390_ijms23084340
crossref_primary_10_1007_s42000_022_00406_6
crossref_primary_10_1210_en_2016_1804
crossref_primary_10_1016_j_ecl_2015_02_009
crossref_primary_10_1093_ejendo_lvad134
crossref_primary_10_1210_jc_2017_00823
crossref_primary_10_1016_j_coemr_2019_08_019
crossref_primary_10_1111_cen_13294
crossref_primary_10_7326_M18_3630
crossref_primary_10_1016_j_med_2023_12_002
crossref_primary_10_1210_jc_2014_3541
crossref_primary_10_4158_EP_2020_0182
crossref_primary_10_1002_ijc_29950
crossref_primary_10_1111_cen_14850
crossref_primary_10_1186_s12893_016_0154_1
crossref_primary_10_1016_j_beem_2020_101427
crossref_primary_10_1111_cen_14811
crossref_primary_10_1007_s40137_016_0145_2
crossref_primary_10_1016_j_ando_2023_01_005
crossref_primary_10_1038_s41598_022_19321_2
crossref_primary_10_4158_EP171897_CR
crossref_primary_10_1007_s00330_019_06202_y
crossref_primary_10_1080_17446651_2018_1543585
crossref_primary_10_1055_a_1827_4113
crossref_primary_10_1210_js_2019_00090
crossref_primary_10_4158_EP161713_OR
crossref_primary_10_1007_s12020_017_1400_8
crossref_primary_10_1007_s12020_018_1696_z
crossref_primary_10_1186_s12933_023_01836_1
crossref_primary_10_2174_1871530318666181009112042
crossref_primary_10_3390_biomedicines11123115
crossref_primary_10_1007_s12020_017_1421_3
crossref_primary_10_1186_s12933_022_01451_6
crossref_primary_10_1007_s12020_019_02066_w
crossref_primary_10_1093_ejendo_lvad066
crossref_primary_10_1001_jamanetworkopen_2024_6453
crossref_primary_10_1007_s12020_023_03396_6
crossref_primary_10_1016_j_beem_2021_101494
crossref_primary_10_1080_17446651_2021_1948327
crossref_primary_10_1210_js_2018_00385
crossref_primary_10_1007_s12020_020_02212_9
crossref_primary_10_1016_j_diabres_2024_111099
crossref_primary_10_1016_j_tem_2015_07_010
crossref_primary_10_1097_MED_0000000000000151
crossref_primary_10_1507_endocrj_EJ18_0066
crossref_primary_10_1097_MED_0000000000000153
crossref_primary_10_1002_jso_27594
crossref_primary_10_3390_medicina56020069
crossref_primary_10_1111_cen_12823
crossref_primary_10_1007_s12020_017_1439_6
crossref_primary_10_1007_s12020_021_02741_x
crossref_primary_10_1210_jc_2018_01029
crossref_primary_10_1007_s40618_017_0644_8
crossref_primary_10_1016_j_jdiacomp_2016_05_006
crossref_primary_10_4158_EP_2019_0047
crossref_primary_10_1530_EC_22_0074
crossref_primary_10_1210_jc_2018_02790
crossref_primary_10_3390_jcm12144612
crossref_primary_10_1097_MED_0000000000000628
crossref_primary_10_1093_ejendo_lvad113
crossref_primary_10_1007_s12020_022_03120_w
crossref_primary_10_1210_clinem_dgad074
crossref_primary_10_3390_jcm12134244
crossref_primary_10_1210_jendso_bvaa079
crossref_primary_10_3109_07435800_2015_1076455
crossref_primary_10_1530_EJE_17_0986
crossref_primary_10_1038_s41371_017_0011_4
crossref_primary_10_1038_s41598_023_48295_y
crossref_primary_10_1001_jamainternmed_2023_5698
crossref_primary_10_1007_s40618_021_01615_3
crossref_primary_10_1007_s40619_022_01148_8
crossref_primary_10_1111_cen_13822
crossref_primary_10_1155_2015_674734
crossref_primary_10_1210_clinem_dgad665
crossref_primary_10_1007_s11845_021_02734_9
crossref_primary_10_1111_cen_13541
crossref_primary_10_1530_EJE_15_0272
crossref_primary_10_1016_j_steroids_2018_08_011
crossref_primary_10_4158_EP14399_OR
crossref_primary_10_1530_EJE_15_0354
Cites_doi 10.1016/j.metabol.2010.01.007
10.1016/S0735-1097(01)01746-6
10.1046/j.1365-2362.2000.0300s3083.x
10.1161/circ.106.25.3143
10.1007/BF03344099
10.1007/BF03345772
10.1093/qjmed/hcm118
10.2147/vhrm.2006.2.1.19
10.4149/neo_2009_06_521
10.7326/0003-4819-128-4-199802150-00002
10.1007/BF03346410
10.1159/000314319
10.1097/SLA.0b013e31819a47d2
10.1530/EJE-10-1147
10.1210/jc.2010-2722
10.1210/jcem.87.3.8277
10.1016/S0735-1097(99)00259-4
10.1530/EJE-11-1039
10.1210/er.2002-0031
10.1016/0735-1097(95)00327-4
10.1172/JCI112886
10.1001/jama.2013.284427
10.1016/j.metabol.2006.12.018
10.1530/eje.0.1480213
10.1111/j.1365-2265.2008.03492.x
10.1530/EJE-08-0707
10.1007/s12020-009-9160-8
10.1210/jcem-20-12-1539
10.1530/eje.0.1490273
10.1210/jc.2001-011766
10.1046/j.1365-2265.2000.01006.x
10.1210/jc.2009-2387
10.1007/BF03347083
10.1056/NEJMcp065470
10.1007/BF03345724
10.1210/jcem.85.7.6661
10.2337/dc13-S011
10.1111/j.1365-2796.2010.02291.x
10.2337/diacare.22.9.1462
10.1111/j.1365-2265.2009.03551.x
10.1210/jc.2010-0633
10.1159/000314272
ContentType Journal Article
Copyright Copyright © 2014 by the Endocrine Society
Copyright © 2014 by The Endocrine Society
2015 INIST-CNRS
Copyright_xml – notice: Copyright © 2014 by the Endocrine Society
– notice: Copyright © 2014 by The Endocrine Society
– notice: 2015 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1210/jc.2013-4064
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 2762
ExternalDocumentID 10_1210_jc_2013_4064
24712565
28919669
00004678-201408000-00021
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
02
08R
0R
1TH
29K
2WC
34G
39C
3O-
3V.
4.4
48X
53G
55
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABJS
AABMN
AAIMJ
AAJQQ
AAPQZ
AAQQT
AAUQX
AAWTL
AAYJJ
ABFLS
ABOCM
ABPMR
ABPPZ
ABSAR
ABUWG
ACGFS
ACIMA
ACPRK
ACUTJ
ADBBV
ADBIT
ADEIU
ADGZP
ADHKW
ADRTK
AELNO
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFNX
AFKRA
AFRAH
AFXEN
AGINJ
AGKRT
AGVJH
AHMBA
AIKOY
AIMBJ
ALMA_UNASSIGNED_HOLDINGS
APIBT
AQKUS
ARIXL
ASMCH
ASPBG
AVWKF
AYOIW
AZFZN
AZQFJ
BAWUL
BAYMD
BBAFP
BCRHZ
BENPR
BEYMZ
BGYMP
BHONS
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CDBKE
CS3
D-I
DAKXR
DIK
DPPUQ
E3Z
EBS
EIHJH
EJD
ENERS
F5P
FEDTE
FH7
FHSFR
FOTVD
FQBLK
FYUFA
G8K
GAUVT
GJ
GJXCC
GX1
H1
H13
HVGLF
HZ
H~9
IAO
IHR
INH
J5H
KBUDW
KOP
KQ8
KSN
L7B
M1P
M5
MBLQV
MHKGH
N9A
NLBLG
NOYVH
NVLIB
O0-
O9-
OBH
OCB
ODMLO
OGEVE
OK1
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
REU
ROX
ROZ
TCN
TJX
TLC
TMA
TWZ
VH1
WOQ
X
X52
X7M
XZ
ZA5
ZGI
ZXP
ZY1
.XZ
3RD
AJYGW
M2M
M5~
ROL
~H1
---
-~X
.55
.GJ
08P
0R~
18M
354
AABZA
AACZT
AAKAS
AAPGJ
AAVAP
AAWDT
ABBLC
ABLJU
ABPTD
ABWST
ACFRR
ACGFO
ADGIM
ADGKP
ADMTO
ADVEK
ADZCM
AERZD
AFFZL
AFGWE
AFOFC
AFXAL
AGQXC
AGUTN
AI.
AJEEA
AQDSO
BYORX
EMOBN
FECEO
FOEOM
HZ~
IQODW
KSI
MJL
N4W
N95
NOMLY
OFXIZ
OHH
OVIDX
P6G
TEORI
TR2
VVN
W8F
WHG
YBU
YFH
YHG
YOC
YSK
~02
AAPXW
AARHZ
AAUAY
ABJNI
ABMNT
ABNHQ
ABPQP
ABQNK
ABXVV
ACYHN
ACZBC
ADQBN
AFYAG
AGMDO
APJGH
ATGXG
AVNTJ
CGR
CUY
CVF
ECM
EIF
FLUFQ
ITC
NPM
OAUYM
OJZSN
OPAEJ
AAYXX
ABEJV
CITATION
7X8
ID FETCH-LOGICAL-c4481-fdfb2ab8fe4b813f4e2834a81752f1f942dbe85d56e86cdb1c51a8c78b56e8003
ISSN 0021-972X
IngestDate Fri Oct 25 21:46:26 EDT 2024
Thu Nov 21 23:45:08 EST 2024
Sat Sep 28 08:00:53 EDT 2024
Fri Nov 25 01:02:28 EST 2022
Thu Aug 13 19:51:00 EDT 2020
Tue Jan 05 21:44:43 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Endocrinopathy
Human
Corticosteroid
Obesity
Nutrition
Steroid hormone
Secretion
Adrenal gland neoplasm
Nutrition disorder
Antiinflammatory agent
Patient
Metabolic diseases
Cardiovascular disease
Cortisol
Hydrocortisone
Glucocorticoid
Adrenal hormone
Adrenal gland diseases
Risk factor
Cardiovascular risk
Endocrinology
Nutritional status
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4481-fdfb2ab8fe4b813f4e2834a81752f1f942dbe85d56e86cdb1c51a8c78b56e8003
Notes Part of this project was funded by University of Athens, Special Account for Research Grants (Kapodistrias).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jcem/article-pdf/99/8/2754/9049328/jcem2754.pdf
PMID 24712565
PQID 1552367616
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1552367616
crossref_primary_10_1210_jc_2013_4064
pubmed_primary_24712565
pascalfrancis_primary_28919669
wolterskluwer_health_00004678-201408000-00021
endocrinepress_journals_10_1210_jc_2013_4064
ProviderPackageCode .XZ
OBH
C45
5RS
AFCHL
OGEVE
~H1
ABPMR
M5~
OVD
OCB
PublicationCentury 2000
PublicationDate 2014-August
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-August
PublicationDecade 2010
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2014
Publisher Endocrine Society
Copyright by The Endocrine Society
Publisher_xml – name: Endocrine Society
– name: Copyright by The Endocrine Society
References Chiodini, I (B35) 2011; 96
Bovio, S; Cataldi, A; Reimondo, G (B4) 2006; 29
(B5) 2002; 19
Vassilatou, E; Vryonidou, A; Michalopoulou, S (B37) 2009; 70
Mansmann, G; Lau, J; Balk, E; Rothberg, M; Miyachi, Y; Bornstein, SR (B1) 2004; 25
Garrapa, GG; Pantanetti, P; Arnaldi, G; Mantero, F; Faloia, E (B9) 2001; 86
Yilmaz, H; Tütüncü, NB; Sahin, M (B13) 2009; 32
Bernini, G; Moretti, A; Iacconi, P (B8) 2003; 148
Young, WF (B6) 2007; 356
Yener, S; Comlekci, A; Akinci, B (B19) 2009; 32
Chiodini, I; Morelli, V; Salcuni, AS (B42) 2010; 95
Anderson, TJ; Uehata, A; Gerhard, MD (B20) 1995; 26
Barzon, L; Sonino, N; Fallo, F; Palu, G; Boscaro, M (B3) 2003; 149
Pivonello, R; De Leo, M; Vitale, P (B38) 2010; 92
Stewart, PM (B45) 2010; 95
Beuschlein, F; Borgemeister, M; Schirra, J (B40) 2000; 52
(B25) 2002; 106
Tauchmanovà, L; Rossi, R; Biondi, B (B34) 2002; 87
Rossi, R; Tauchmanova, L; Luciano, A (B7) 2000; 85
Terzolo, M; Stigliano, A; Chiodini, I (B2) 2011; 164
Piaditis, GP; Kaltsas, GA; Androulakis, II (B32) 2009; 71
James, PA; Oparil, S; Carter, BL (B24) 2014; 311
Liddle, GW (B31) 1960; 20
Yener, S; Baris, M; Secil, M; Akinci, B; Comlekci, A; Yesil, S (B16) 2011; 34
Katz, A; Nambi, SS; Mather, K (B29) 2000; 85
Di Dalmazi, G; Vicennati, V; Rinaldi, E (B36) 2012; 166
Bergman, RN; Prager, R; Volund, A; Olefsky, JM (B28) 1987; 79
Sereg, M; Szappanos, A; Toke, J (B44) 2009; 160
Terzolo, M; Pia, A; Alì, A (B10) 2002; 87
Peppa, M; Koliaki, C; Raptis, SA (B11) 2010; 268
Matsuda, M; DeFronzo, RA (B30) 1999; 22
Alexandraki, KI; Makras, P; Protogerou, AD (B26) 2008; 101
Corretti, MC; Anderson, TJ; Benjamin, EJ (B27) 2002; 39
Wagnerova, H; Dudasova, D; Lazurova, I (B14) 2009; 56
Yener, S; Genc, S; Akinci, B (B15) 2009; 35
Anderson, TJ (B22) 1999; 34
Toniato, A; Merante-Boschin, I; Opocher, G; Pelizzo, MR; Schiavi, F; Ballotta, E (B43) 2009; 249
Ermetici, F; Malavazos, AE; Corbetta, S (B18) 2007; 56
Ermetici, F; Dall'Asta, C; Malavazos, AE (B17) 2008; 31
Peppa, M; Boutati, E; Koliaki, C (B12) 2010; 59
Lane, HA; Smith, JC; Davies, JS (B23) 2006; 2
(B33) 2013; 36
Dall'Asta, C; Barbetta, L; Libé, R; Passini, E; Ambrosi, B (B39) 2002; 57
Chanson, P; Salenave, S (B46) 2010; 92
Maser-Gluth, C; Reincke, M; Allolio, B; Schulze, E (B41) 2000; 30
Hodis, HN; Mack, WJ; LaBree, L (B21) 1998; 128
25539001 - J Clin Endocrinol Metab. 2014 Nov;99(11):L3
25539000 - J Clin Endocrinol Metab. 2014 Nov;99(11):L1-2
Terzolo (2020071613511828800_B2) 2011; 164
Piaditis (2020071613511828800_B32) 2009; 71
Young (2020071613511828800_B6) 2007; 356
Bergman (2020071613511828800_B28) 1987; 79
Peppa (2020071613511828800_B12) 2010; 59
Corretti (2020071613511828800_B27) 2002; 39
Pivonello (2020071613511828800_B38) 2010; 92
Liddle (2020071613511828800_B31) 1960; 20
Ermetici (2020071613511828800_B17) 2008; 31
Anderson (2020071613511828800_B22) 1999; 34
Garrapa (2020071613511828800_B9) 2001; 86
Beuschlein (2020071613511828800_B40) 2000; 52
Terzolo (2020071613511828800_B10) 2002; 87
Yener (2020071613511828800_B16) 2011; 34
Yener (2020071613511828800_B19) 2009; 32
Mansmann (2020071613511828800_B1) 2004; 25
Maser-Gluth (2020071613511828800_B41) 2000; 30
James (2020071613511828800_B24) 2014; 311
Di Dalmazi (2020071613511828800_B36) 2012; 166
(2020071613511828800_B5) 2002; 19
Bovio (2020071613511828800_B4) 2006; 29
Hodis (2020071613511828800_B21) 1998; 128
Rossi (2020071613511828800_B7) 2000; 85
American Diabetes Association (2020071613511828800_B33) 2013; 36
Alexandraki (2020071613511828800_B26) 2008; 101
Chiodini (2020071613511828800_B35) 2011; 96
Vassilatou (2020071613511828800_B37) 2009; 70
Barzon (2020071613511828800_B3) 2003; 149
Yener (2020071613511828800_B15) 2009; 35
Toniato (2020071613511828800_B43) 2009; 249
Ermetici (2020071613511828800_B18) 2007; 56
Chanson (2020071613511828800_B46) 2010; 92
Bernini (2020071613511828800_B8) 2003; 148
Tauchmanovà (2020071613511828800_B34) 2002; 87
Anderson (2020071613511828800_B20) 1995; 26
Chiodini (2020071613511828800_B42) 2010; 95
Dall'Asta (2020071613511828800_B39) 2002; 57
Yilmaz (2020071613511828800_B13) 2009; 32
Wagnerova (2020071613511828800_B14) 2009; 56
Matsuda (2020071613511828800_B30) 1999; 22
Stewart (2020071613511828800_B45) 2010; 95
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2020071613511828800_B25) 2002; 106
Peppa (2020071613511828800_B11) 2010; 268
Katz (2020071613511828800_B29) 2000; 85
Lane (2020071613511828800_B23) 2006; 2
Sereg (2020071613511828800_B44) 2009; 160
References_xml – volume: 19
  start-page: 1
  year: 2002
  end-page: 25
  ident: B5
  article-title: NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”)
  publication-title: NIH Consens State Sci Statements
– volume: 86
  start-page: 5301
  year: 2001
  end-page: 5306
  ident: B9
  article-title: Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Garrapa, GG; Pantanetti, P; Arnaldi, G; Mantero, F; Faloia, E
– volume: 22
  start-page: 1462
  year: 1999
  end-page: 1470
  ident: B30
  article-title: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
  publication-title: Diabetes Care
  contributor:
    fullname: Matsuda, M; DeFronzo, RA
– volume: 356
  start-page: 601
  year: 2007
  end-page: 610
  ident: B6
  article-title: Clinical practice. The incidentally discovered adrenal mass
  publication-title: N Engl J Med
  contributor:
    fullname: Young, WF
– volume: 32
  start-page: 338
  year: 2009
  end-page: 343
  ident: B19
  article-title: Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Yener, S; Comlekci, A; Akinci, B
– volume: 101
  start-page: 31
  year: 2008
  end-page: 40
  ident: B26
  article-title: Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities
  publication-title: QJM
  contributor:
    fullname: Alexandraki, KI; Makras, P; Protogerou, AD
– volume: 30
  start-page: 83
  year: 2000
  end-page: 86
  ident: B41
  article-title: Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas
  publication-title: Eur J Clin Invest
  contributor:
    fullname: Maser-Gluth, C; Reincke, M; Allolio, B; Schulze, E
– volume: 34
  start-page: 265
  year: 2011
  end-page: 270
  ident: B16
  article-title: Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Yener, S; Baris, M; Secil, M; Akinci, B; Comlekci, A; Yesil, S
– volume: 56
  start-page: 686
  year: 2007
  end-page: 692
  ident: B18
  article-title: Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma
  publication-title: Metabolism
  contributor:
    fullname: Ermetici, F; Malavazos, AE; Corbetta, S
– volume: 36
  start-page: S11
  year: 2013
  end-page: S66
  ident: B33
  article-title: Standards of medical care in diabetes–2013
  publication-title: Diabetes Care
– volume: 106
  start-page: 3143
  year: 2002
  end-page: 3421
  ident: B25
  article-title: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
  publication-title: Circulation
– volume: 92
  start-page: 96
  year: 2010
  end-page: 101
  ident: B46
  article-title: Metabolic syndrome in Cushing's syndrome
  publication-title: Neuroendocrinology
  contributor:
    fullname: Chanson, P; Salenave, S
– volume: 32
  start-page: 913
  year: 2009
  end-page: 916
  ident: B13
  article-title: Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Yilmaz, H; Tütüncü, NB; Sahin, M
– volume: 57
  start-page: 192
  year: 2002
  end-page: 196
  ident: B39
  article-title: Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome
  publication-title: Horm Res
  contributor:
    fullname: Dall'Asta, C; Barbetta, L; Libé, R; Passini, E; Ambrosi, B
– volume: 71
  start-page: 772
  year: 2009
  end-page: 778
  ident: B32
  article-title: High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas
  publication-title: Clin Endocrinol (Oxf)
  contributor:
    fullname: Piaditis, GP; Kaltsas, GA; Androulakis, II
– volume: 70
  start-page: 674
  year: 2009
  end-page: 679
  ident: B37
  article-title: Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study
  publication-title: Clin Endocrinol (Oxf)
  contributor:
    fullname: Vassilatou, E; Vryonidou, A; Michalopoulou, S
– volume: 92
  start-page: 77
  year: 2010
  end-page: 81
  ident: B38
  article-title: Pathophysiology of diabetes mellitus in Cushing's syndrome
  publication-title: Neuroendocrinology
  contributor:
    fullname: Pivonello, R; De Leo, M; Vitale, P
– volume: 35
  start-page: 365
  year: 2009
  end-page: 370
  ident: B15
  article-title: Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma
  publication-title: Endocrine
  contributor:
    fullname: Yener, S; Genc, S; Akinci, B
– volume: 59
  start-page: 1435
  year: 2010
  end-page: 1441
  ident: B12
  article-title: Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
  publication-title: Metabolism
  contributor:
    fullname: Peppa, M; Boutati, E; Koliaki, C
– volume: 311
  start-page: 507
  year: 2014
  end-page: 520
  ident: B24
  article-title: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
  publication-title: JAMA
  contributor:
    fullname: James, PA; Oparil, S; Carter, BL
– volume: 166
  start-page: 669
  year: 2012
  end-page: 677
  ident: B36
  article-title: Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
  publication-title: Eur J Endocrinol
  contributor:
    fullname: Di Dalmazi, G; Vicennati, V; Rinaldi, E
– volume: 95
  start-page: 2618
  year: 2010
  end-page: 2620
  ident: B45
  article-title: Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Stewart, PM
– volume: 31
  start-page: 573
  year: 2008
  end-page: 577
  ident: B17
  article-title: Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Ermetici, F; Dall'Asta, C; Malavazos, AE
– volume: 95
  start-page: 2736
  year: 2010
  end-page: 2745
  ident: B42
  article-title: Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Chiodini, I; Morelli, V; Salcuni, AS
– volume: 79
  start-page: 790
  year: 1987
  end-page: 800
  ident: B28
  article-title: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp
  publication-title: J Clin Invest
  contributor:
    fullname: Bergman, RN; Prager, R; Volund, A; Olefsky, JM
– volume: 96
  start-page: 1223
  year: 2011
  end-page: 1236
  ident: B35
  article-title: Clinical review: Diagnosis and treatment of subclinical hypercortisolism
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Chiodini, I
– volume: 34
  start-page: 631
  year: 1999
  end-page: 638
  ident: B22
  article-title: Assessment and treatment of endothelial dysfunction in humans
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Anderson, TJ
– volume: 160
  start-page: 647
  year: 2009
  end-page: 655
  ident: B44
  article-title: Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study
  publication-title: Eur J Endocrinol
  contributor:
    fullname: Sereg, M; Szappanos, A; Toke, J
– volume: 148
  start-page: 213
  year: 2003
  end-page: 219
  ident: B8
  article-title: Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery
  publication-title: Eur J Endocrinol
  contributor:
    fullname: Bernini, G; Moretti, A; Iacconi, P
– volume: 85
  start-page: 2402
  year: 2000
  end-page: 2410
  ident: B29
  article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Katz, A; Nambi, SS; Mather, K
– volume: 87
  start-page: 4872
  year: 2002
  end-page: 4878
  ident: B34
  article-title: Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Tauchmanovà, L; Rossi, R; Biondi, B
– volume: 20
  start-page: 1539
  year: 1960
  end-page: 1560
  ident: B31
  article-title: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Liddle, GW
– volume: 128
  start-page: 262
  year: 1998
  end-page: 269
  ident: B21
  article-title: The role of carotid arterial intima-media thickness in predicting clinical coronary events
  publication-title: Ann Intern Med
  contributor:
    fullname: Hodis, HN; Mack, WJ; LaBree, L
– volume: 26
  start-page: 1235
  year: 1995
  end-page: 1241
  ident: B20
  article-title: Close relation of endothelial function in the human coronary and peripheral circulations
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Anderson, TJ; Uehata, A; Gerhard, MD
– volume: 2
  start-page: 19
  year: 2006
  end-page: 30
  ident: B23
  article-title: Noninvasive assessment of preclinical atherosclerosis
  publication-title: Vasc Health Risk Manag
  contributor:
    fullname: Lane, HA; Smith, JC; Davies, JS
– volume: 85
  start-page: 1440
  year: 2000
  end-page: 1448
  ident: B7
  article-title: Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Rossi, R; Tauchmanova, L; Luciano, A
– volume: 25
  start-page: 309
  year: 2004
  end-page: 340
  ident: B1
  article-title: The clinically inapparent adrenal mass: update in diagnosis and management
  publication-title: Endocr Rev
  contributor:
    fullname: Mansmann, G; Lau, J; Balk, E; Rothberg, M; Miyachi, Y; Bornstein, SR
– volume: 164
  start-page: 851
  year: 2011
  end-page: 870
  ident: B2
  article-title: AME position statement on adrenal incidentaloma
  publication-title: Eur J Endocrinol
  contributor:
    fullname: Terzolo, M; Stigliano, A; Chiodini, I
– volume: 149
  start-page: 273
  year: 2003
  end-page: 285
  ident: B3
  article-title: Prevalence and natural history of adrenal incidentalomas
  publication-title: Eur J Endocrinol
  contributor:
    fullname: Barzon, L; Sonino, N; Fallo, F; Palu, G; Boscaro, M
– volume: 39
  start-page: 257
  year: 2002
  end-page: 265
  ident: B27
  article-title: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Corretti, MC; Anderson, TJ; Benjamin, EJ
– volume: 249
  start-page: 388
  year: 2009
  end-page: 391
  ident: B43
  article-title: Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study
  publication-title: Ann Surg
  contributor:
    fullname: Toniato, A; Merante-Boschin, I; Opocher, G; Pelizzo, MR; Schiavi, F; Ballotta, E
– volume: 29
  start-page: 298
  year: 2006
  end-page: 302
  ident: B4
  article-title: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
  publication-title: J Endocrinol Invest
  contributor:
    fullname: Bovio, S; Cataldi, A; Reimondo, G
– volume: 52
  start-page: 617
  year: 2000
  end-page: 623
  ident: B40
  article-title: Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas
  publication-title: Clin Endocrinol (Oxf)
  contributor:
    fullname: Beuschlein, F; Borgemeister, M; Schirra, J
– volume: 87
  start-page: 998
  year: 2002
  end-page: 1003
  ident: B10
  article-title: Adrenal incidentaloma: a new cause of the metabolic syndrome?
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Terzolo, M; Pia, A; Alì, A
– volume: 56
  start-page: 521
  year: 2009
  end-page: 525
  ident: B14
  article-title: Hormonal and metabolic evaluation of adrenal incidentalomas
  publication-title: Neoplasma
  contributor:
    fullname: Wagnerova, H; Dudasova, D; Lazurova, I
– volume: 268
  start-page: 555
  year: 2010
  end-page: 566
  ident: B11
  article-title: Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications
  publication-title: J Intern Med
  contributor:
    fullname: Peppa, M; Koliaki, C; Raptis, SA
– volume: 59
  start-page: 1435
  year: 2010
  ident: 2020071613511828800_B12
  article-title: Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2010.01.007
  contributor:
    fullname: Peppa
– volume: 39
  start-page: 257
  year: 2002
  ident: 2020071613511828800_B27
  article-title: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(01)01746-6
  contributor:
    fullname: Corretti
– volume: 30
  start-page: 83
  year: 2000
  ident: 2020071613511828800_B41
  article-title: Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas
  publication-title: Eur J Clin Invest
  doi: 10.1046/j.1365-2362.2000.0300s3083.x
  contributor:
    fullname: Maser-Gluth
– volume: 106
  start-page: 3143
  year: 2002
  ident: 2020071613511828800_B25
  article-title: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
  contributor:
    fullname: National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
– volume: 29
  start-page: 298
  year: 2006
  ident: 2020071613511828800_B4
  article-title: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03344099
  contributor:
    fullname: Bovio
– volume: 32
  start-page: 913
  year: 2009
  ident: 2020071613511828800_B13
  article-title: Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03345772
  contributor:
    fullname: Yilmaz
– volume: 101
  start-page: 31
  year: 2008
  ident: 2020071613511828800_B26
  article-title: Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities
  publication-title: QJM
  doi: 10.1093/qjmed/hcm118
  contributor:
    fullname: Alexandraki
– volume: 2
  start-page: 19
  year: 2006
  ident: 2020071613511828800_B23
  article-title: Noninvasive assessment of preclinical atherosclerosis
  publication-title: Vasc Health Risk Manag
  doi: 10.2147/vhrm.2006.2.1.19
  contributor:
    fullname: Lane
– volume: 56
  start-page: 521
  year: 2009
  ident: 2020071613511828800_B14
  article-title: Hormonal and metabolic evaluation of adrenal incidentalomas
  publication-title: Neoplasma
  doi: 10.4149/neo_2009_06_521
  contributor:
    fullname: Wagnerova
– volume: 128
  start-page: 262
  year: 1998
  ident: 2020071613511828800_B21
  article-title: The role of carotid arterial intima-media thickness in predicting clinical coronary events
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-128-4-199802150-00002
  contributor:
    fullname: Hodis
– volume: 31
  start-page: 573
  year: 2008
  ident: 2020071613511828800_B17
  article-title: Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03346410
  contributor:
    fullname: Ermetici
– volume: 92
  start-page: 77
  year: 2010
  ident: 2020071613511828800_B38
  article-title: Pathophysiology of diabetes mellitus in Cushing's syndrome
  publication-title: Neuroendocrinology
  doi: 10.1159/000314319
  contributor:
    fullname: Pivonello
– volume: 249
  start-page: 388
  year: 2009
  ident: 2020071613511828800_B43
  article-title: Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31819a47d2
  contributor:
    fullname: Toniato
– volume: 19
  start-page: 1
  year: 2002
  ident: 2020071613511828800_B5
  article-title: NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”)
  publication-title: NIH Consens State Sci Statements
– volume: 164
  start-page: 851
  year: 2011
  ident: 2020071613511828800_B2
  article-title: AME position statement on adrenal incidentaloma
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-10-1147
  contributor:
    fullname: Terzolo
– volume: 96
  start-page: 1223
  year: 2011
  ident: 2020071613511828800_B35
  article-title: Clinical review: Diagnosis and treatment of subclinical hypercortisolism
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-2722
  contributor:
    fullname: Chiodini
– volume: 87
  start-page: 998
  year: 2002
  ident: 2020071613511828800_B10
  article-title: Adrenal incidentaloma: a new cause of the metabolic syndrome?
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.3.8277
  contributor:
    fullname: Terzolo
– volume: 34
  start-page: 631
  year: 1999
  ident: 2020071613511828800_B22
  article-title: Assessment and treatment of endothelial dysfunction in humans
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(99)00259-4
  contributor:
    fullname: Anderson
– volume: 57
  start-page: 192
  year: 2002
  ident: 2020071613511828800_B39
  article-title: Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome
  publication-title: Horm Res
  contributor:
    fullname: Dall'Asta
– volume: 166
  start-page: 669
  year: 2012
  ident: 2020071613511828800_B36
  article-title: Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-11-1039
  contributor:
    fullname: Di Dalmazi
– volume: 25
  start-page: 309
  year: 2004
  ident: 2020071613511828800_B1
  article-title: The clinically inapparent adrenal mass: update in diagnosis and management
  publication-title: Endocr Rev
  doi: 10.1210/er.2002-0031
  contributor:
    fullname: Mansmann
– volume: 26
  start-page: 1235
  year: 1995
  ident: 2020071613511828800_B20
  article-title: Close relation of endothelial function in the human coronary and peripheral circulations
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(95)00327-4
  contributor:
    fullname: Anderson
– volume: 79
  start-page: 790
  year: 1987
  ident: 2020071613511828800_B28
  article-title: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp
  publication-title: J Clin Invest
  doi: 10.1172/JCI112886
  contributor:
    fullname: Bergman
– volume: 311
  start-page: 507
  year: 2014
  ident: 2020071613511828800_B24
  article-title: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
  publication-title: JAMA
  doi: 10.1001/jama.2013.284427
  contributor:
    fullname: James
– volume: 56
  start-page: 686
  year: 2007
  ident: 2020071613511828800_B18
  article-title: Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2006.12.018
  contributor:
    fullname: Ermetici
– volume: 86
  start-page: 5301
  year: 2001
  ident: 2020071613511828800_B9
  article-title: Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Garrapa
– volume: 148
  start-page: 213
  year: 2003
  ident: 2020071613511828800_B8
  article-title: Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.0.1480213
  contributor:
    fullname: Bernini
– volume: 70
  start-page: 674
  year: 2009
  ident: 2020071613511828800_B37
  article-title: Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2008.03492.x
  contributor:
    fullname: Vassilatou
– volume: 160
  start-page: 647
  year: 2009
  ident: 2020071613511828800_B44
  article-title: Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-08-0707
  contributor:
    fullname: Sereg
– volume: 35
  start-page: 365
  year: 2009
  ident: 2020071613511828800_B15
  article-title: Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma
  publication-title: Endocrine
  doi: 10.1007/s12020-009-9160-8
  contributor:
    fullname: Yener
– volume: 20
  start-page: 1539
  year: 1960
  ident: 2020071613511828800_B31
  article-title: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-20-12-1539
  contributor:
    fullname: Liddle
– volume: 85
  start-page: 1440
  year: 2000
  ident: 2020071613511828800_B7
  article-title: Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Rossi
– volume: 149
  start-page: 273
  year: 2003
  ident: 2020071613511828800_B3
  article-title: Prevalence and natural history of adrenal incidentalomas
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje.0.1490273
  contributor:
    fullname: Barzon
– volume: 87
  start-page: 4872
  year: 2002
  ident: 2020071613511828800_B34
  article-title: Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2001-011766
  contributor:
    fullname: Tauchmanovà
– volume: 52
  start-page: 617
  year: 2000
  ident: 2020071613511828800_B40
  article-title: Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1046/j.1365-2265.2000.01006.x
  contributor:
    fullname: Beuschlein
– volume: 95
  start-page: 2736
  year: 2010
  ident: 2020071613511828800_B42
  article-title: Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-2387
  contributor:
    fullname: Chiodini
– volume: 34
  start-page: 265
  year: 2011
  ident: 2020071613511828800_B16
  article-title: Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03347083
  contributor:
    fullname: Yener
– volume: 356
  start-page: 601
  year: 2007
  ident: 2020071613511828800_B6
  article-title: Clinical practice. The incidentally discovered adrenal mass
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp065470
  contributor:
    fullname: Young
– volume: 32
  start-page: 338
  year: 2009
  ident: 2020071613511828800_B19
  article-title: Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03345724
  contributor:
    fullname: Yener
– volume: 85
  start-page: 2402
  year: 2000
  ident: 2020071613511828800_B29
  article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.85.7.6661
  contributor:
    fullname: Katz
– volume: 36
  start-page: S11
  year: 2013
  ident: 2020071613511828800_B33
  article-title: Standards of medical care in diabetes–2013
  publication-title: Diabetes Care
  doi: 10.2337/dc13-S011
  contributor:
    fullname: American Diabetes Association
– volume: 268
  start-page: 555
  year: 2010
  ident: 2020071613511828800_B11
  article-title: Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2010.02291.x
  contributor:
    fullname: Peppa
– volume: 22
  start-page: 1462
  year: 1999
  ident: 2020071613511828800_B30
  article-title: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.9.1462
  contributor:
    fullname: Matsuda
– volume: 71
  start-page: 772
  year: 2009
  ident: 2020071613511828800_B32
  article-title: High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2009.03551.x
  contributor:
    fullname: Piaditis
– volume: 95
  start-page: 2618
  year: 2010
  ident: 2020071613511828800_B45
  article-title: Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0633
  contributor:
    fullname: Stewart
– volume: 92
  start-page: 96
  year: 2010
  ident: 2020071613511828800_B46
  article-title: Metabolic syndrome in Cushing's syndrome
  publication-title: Neuroendocrinology
  doi: 10.1159/000314272
  contributor:
    fullname: Chanson
SSID ssj0014453
Score 2.5133777
Snippet Context: Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients...
CONTEXT:Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with...
Although adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with...
CONTEXTAlthough adrenal incidentalomas (AIs) are associated with a high prevalence of cardiovascular risk (CVR) factors, it is not clear whether patients with...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
endocrinepress
SourceType Aggregation Database
Index Database
Publisher
StartPage 2754
SubjectTerms Adrenal Gland Neoplasms - blood
Adrenal Gland Neoplasms - epidemiology
Adrenal Gland Neoplasms - secretion
Biological and medical sciences
Cardiovascular Diseases - blood
Cardiovascular Diseases - diagnostic imaging
Cardiovascular Diseases - epidemiology
Carotid Intima-Media Thickness
Case-Control Studies
Endocrinopathies
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Glucose Tolerance Test
Hemodynamics
Humans
Hydrocortisone - blood
Hydrocortisone - secretion
Insulin Resistance
Male
Medical sciences
Middle Aged
Risk Factors
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vertebrates: endocrinology
Title Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion
URI http://dx.doi.org/10.1210/jc.2013-4064
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201408000-00021
https://www.ncbi.nlm.nih.gov/pubmed/24712565
https://search.proquest.com/docview/1552367616
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6TUI8gLiOcpmMBE8lUp3aqfs4oNPQxkCim_oW2bEjbWubaUkF-wv8as6J7aQRII0HXqLKSh0l35dzy7kQ8maY5JipYyLFxDjio0xEwBsbKWEULAkrDIYGDr-NT-by45RPe70w_qZd-69IwxpgjZWz_4B2sykswG_AHI6AOhxvhftX1yg1VK1dYYb5qlrcDMDPRyUWArAKS7jrjhsZzhXFIM5SlYOluhlg-gVODkCDsgSDNOvmrNbZ6GZdz9ywP7DMALOPwIutzuHWBiUaog3cFy0bN5pUNPWYdmUKkFurthPU0lbAy0XobFhHKMx1AVe-dO0QPhU4Zqlsw71HalGVri7NV9y0Adoj7Dmu2uj_eVG2tRdYp1Ssa-lY4RhxHzH2MRDGmww8UGFObk-4iMbMpfoGwe4mL3kCy00pPXaNq73Gj71C-E2bgDuM2gQ7XbIReNoJb7VmyBQ4-ZIenB4fp7PpfLZFdmKQdyBud_bfz8_Oms9ZnIuRr7rAkqnNHTv20L3w1F0WNCbqArZqkbshK3_yguCc7wUmVpSXdV3FhnU0e0Due7eG7js-PiQ9u3pE7nz2iRuPyc9AS4q0pC0taZeW1NOSdmlJgZZUW6oq2tCSdmlJkZYUaEmrgja0pIGWtKHlE3J6MJ19OIz8GJAo41yyKDe5jpWWueVaslHOLZjEXEkwfOOc5RMeG22lMCKxMsmMZplgSmZjqXEFtNZTsg33Yp8RannCmMZic615pqRMNBsmQyW15dlQyz55G8BIr1y3lxS9ZAAtvchSBC1F0PrkXRep1L9C5V9O3-vg2OwdywlowGTSJ68DsCmId_xmp1a2WMN2QmCPxYQlfbLrEG__DYYleCyiT6IOBVJXQp3W_j8YoxG-MugZ1j0kYvb8Fld7Qe62L9pLsl1dr-0rslWa9Z4n9y_nAOhF
link.rule.ids 315,782,786,27933,27934
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patients+with+apparently+nonfunctioning+adrenal+incidentalomas+may+be+at+increased+cardiovascular+risk+due+to+excessive+cortisol+secretion&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Androulakis%2C+Ioannis+I&rft.au=Kaltsas%2C+Gregory+A&rft.au=Kollias%2C+Georgios+E&rft.au=Markou%2C+Athina+C&rft.date=2014-08-01&rft.eissn=1945-7197&rft.volume=99&rft.issue=8&rft.spage=2754&rft.epage=2762&rft_id=info:doi/10.1210%2Fjc.2013-4064&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon